Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes.

D, Kim; L, MacConell; D, Zhuang; PA, Kothare; M, Trautmann; M, Fineman; K, Taylor

doi:10.2337/dc06-2375

Public

Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes.

Shared by NobleBlocks on Mar 12, 2007 • 12:00 AM UTC

Authors:

Kim D

MacConell L

Zhuang D

Abstract

<h4>Objective</h4>In patients with type 2 diabetes, exenatide reduces A1C, postprandial and fasting glucose, and weight. In this study we investigated the effects of continuous exenatide administration from a long-acting release (LAR) formulation.<h4>Research design and methods</h4>In this randomize...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!